Bicycle Therapeutics plc (BCYC) Misses Q1 EPS by 22c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts BCYC Hot Sheet
Join SI Premium – FREE
Bicycle Therapeutics plc (NASDAQ: BCYC) reported Q1 EPS of ($1.30), $0.22 worse than the analyst estimate of ($1.08). Revenue for the quarter came in at $4.9 million versus the consensus estimate of $3.87 million.
For earnings history and earnings-related data on Bicycle Therapeutics plc (BCYC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Robinhood shares fall on Q3 revenue miss even as EPS beats
- NBT Bancorp (NBTB) Tops Q3 EPS by 2c
- Miv Therapeutics, Inc. (IVT) Tops Q3 EPS by 21c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
